Fundamentals Hub
BIOM BIOMOLECULAR LIFE HOLDINGS, INC.
BIOM financial statements, revenue, balance sheet, cash flow, and SEC filings
▼ Company Profile
▼ Key Metrics (TTM)
As of Sep 30, 2015Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
| Metric | FY2014 📄 | FY2013 📄 |
|---|---|---|
| Income Statement | ||
| REVENUE | ||
| Revenue | $0 | $0 |
| OPERATING EXPENSES | ||
| R&D Expense | $865.70K | $808.52K |
| SG&A Expense | $911.36K | $1.35M |
| Operating Income | $-4.14M | $-3.91M |
| NON-OPERATING INCOME / EXPENSE | ||
| Interest Expense | $2.76M | $1.08M |
| Other Income/Expense | $-2.08M | $-3.57M |
| Income Tax | $0 | $0 |
| Net Income | $-6.19M | $-7.42M |
| PER SHARE & SUPPLEMENTAL | ||
| Diluted EPS | $-0.22 | $-0.91 |
| Diluted Shares | 27.63M | 8.19M |
| EBITDA | $-4.14M | $-3.91M |
| Depreciation & Amortization | $0 | $0 |
| Balance Sheet | ||
| ASSETS | ||
| Other Current Assets | $212.27K | $75.49K |
| Current Assets | $246.27K | $789.39K |
| PP&E (Net) | $0 | $0 |
| Intangible Assets | $1.08M | $1.08M |
| Noncurrent Assets | $1.08M | $1.08M |
| Total Assets | $1.32M | $1.87M |
| LIABILITIES | ||
| Accounts Payable | $710.35K | $405.00K |
| Current Liabilities | $5.83M | $6.33M |
| Noncurrent Liabilities | $-664.51K | $-698.92K |
| Total Liabilities | $5.16M | $5.64M |
| EQUITY | ||
| Common Stock | $4.62K | $1.75K |
| Additional Paid-in Capital | $100.79M | $94.61M |
| Retained Earnings | $-105.97M | $-99.78M |
| Total Equity | $-3.84M | $-3.77M |
| Total Liabilities & Equity | $1.32M | $1.87M |
| SUPPLEMENTAL | ||
| Shares Outstanding | 46.22M | 17.46M |
| Check: A − (L + E + Temp. Equity) | - | - |
| Cash Flow Statement | ||
| Cash from Operations | $-1.91M | $-1.04M |
| Capital Expenditures | $0 | $0 |
| Cash from Investing | $0 | $0 |
| Cash from Financing | $1.23M | $1.75M |
| Free Cash Flow | $-1.91M | $-1.04M |
| Beginning Cash (CFS) | $713.89K | $6.09K |
| Net Change in Cash | $-679.90K | $707.80K |
| Effect of FX on Cash | - | - |
| Calculated Ending Cash | $33.99K | $713.89K |
| Cash per BS | - | - |
| Cash scope difference (CFS − BS) | - | - |
| Cash per CFS | $33.99K | $713.89K |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log InQuarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
What is BIOMOLECULAR LIFE HOLDINGS, INC.'s annual revenue?
BIOMOLECULAR LIFE HOLDINGS, INC. reported $0 in revenue for trailing twelve months (ending September 2015). Revenue figures are sourced from the company's annual SEC EDGAR filing.
Is BIOMOLECULAR LIFE HOLDINGS, INC. profitable?
No. BIOMOLECULAR LIFE HOLDINGS, INC. reported $-4.30M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.